Latest Stock Market News

In CY24, a total of 1,145 IPOs were launched globally, down from 1,271 in the previous year.

The edible oils segment of Adani Wilmar saw consumer downtrading, but the company retained its market share through a diverse brand portfolio across price points. In the foods category, key packaged products like wheat flour, rice, nuggets, pulses, poha, and sugar achieved strong double-digit growth, according to the update.

Rate this item

(1 Vote)

Cybercriminals now target everyday investors, not just large businesses or the wealthy, using sophisticated tactics to exploit vulnerabilities. A common method is phishing, where fraudsters impersonate trusted financial institutions or advisors through emails or messages. Their goal is to deceive individuals into revealing sensitive information, such as passwords, compromising their financial security. Stay vigilant against such scams.

The record date is the cut-off used by companies to determine which shareholders are eligible for corporate benefits. To qualify for buybacks, bonus issues, or stock splits, shareholders must have the shares in their demat accounts as of the record date.

Vedanta posted a Rs 5,603 crore profit in Q2 FY24, rebounding from a Rs 915 crore loss last year, despite a 4% YoY decline in revenue to Rs 37,171 crore, reflecting improved operational performance and recovery.

In Q3 FY25, Bajaj Finance’s AUM grew by Rs 24,100 crore, driven by strong demand across lending segments. New loans booked during the quarter hit a record 12.06 million, marking a 22% YoY increase from 9.86 million in the same period last year, showcasing robust growth momentum.

Fifty smallcap stocks posted double-digit weekly returns, with three surpassing 25%. Apollo Micro Systems led with a 41% gain, followed by ITI Ltd at 39% and Manoj Vaibhav Gems at 25%. Additionally, Epack Durable, Lloyds Metals, and JSW Holdings delivered returns ranging from 20% to 25%, showcasing robust performance in the smallcap segment this week.

InCred healthcare portfolio offers a structural investment product that invests in 5 different baskets of businesses like Branded Generics, Hospitals, Diagnostics, CDMO/API, Generics. The investment framework follows a bottom-up strategy to prepare a concentrated portfolio of 15-20 stocks, which are expected to deliver high double-digit earnings growth with a potential for valuation multiple expansion.

Rate this item

(1 Vote)

A report by Motilal Oswal highlights the resilience of developed Asian markets and the US, contrasting with the challenges faced by emerging markets.

Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.